Molecular origin(s) of the diverse behavioral responses to anticholinesterases were explored in behaviorally impaired transgenic (Tg) FVB/N mice expressing synaptic human acetylcholinesterase (hAChE-S). Untreated hAChE-S Tg, unlike naïve FVB/N mice, presented variably intense neuronal overexpression of the alternatively spliced, stress-induced mouse 'readthrough' mAChE-R mRNA. Both strains displayed similar diurnal patterns of locomotor activity that were impaired 3 days after a day-to-night switch. However, hAChE-S Tg, but not FVB/N mice responded to the circadian switch with irregular, diverse bursts of increased locomotor activity. In social recognition tests, controls displayed short-term recognition, reflected by decreased exploration of a familiar, compared to a novel juvenile conspecific as well as inverse correlation between social recognition and cortical and hippocampal AChE specific activities. In contrast, transgenics presented poor recognition, retrievable by tetrahydroaminoacridine (tacrine, 1.5 mg kg −1 ). Tacrine's effect was short-lived (Ͻ40 min), suggesting its effect was overcome by anticholinesterase-induced overproduction of mAChE-R. Consistent with this hypothesis, antisense oligonucleotides (two daily intracerebroventricular injections of 25 ng) arrested mAChE-R synthesis, selectively reduced mAChE-R levels and afforded an extended (Ͼ24 h) suppression of the abnormal social recognition pattern in transgenics. Efficacy of antisense treatment was directly correlated with AChE-R levels and the severity of the impaired phenotype, being most apparent in transgenics presenting highly abnormal pretreatment behavior. These findings demonstrate that neuronal AChE-R overproduction is involved in various behavioral impairments and anticholinesterase responses, and point to the antisense strategy as a potential approach for re-establishing cholinergic balance.
Introduction
Social behavior is a complex phenotype, composed of the individual's general level of activity, cognitive perception and anticipation of the outcome of such behavior. 1 Working and storage memory and the ability to integrate information can also contribute towards social behavior, which is tightly linked to cholinergic neurotransmission. For example, the hypocholinergic features of Alzheimer's disease (AD) patients include aggressive behavior and/or avoidance of novel social challenges, 2 as well as fears of social interactions alleviated by treatment with anticholinesterases. AChE-S Tg mice constitutively overexpress AChE-R mRNA in their intestinal epithelium. When exposed to an organophosphate anticholinesterase (DFP), they fail to increase further the already overproduced AChE-R, and present extreme DFP sensitivity. Humans with inherited AChE overexpression are likewise hypersensitive to the anticholinesterase pyridostigmine. 12 Our working hypothesis postulated that at appropriate levels, AChE-R accumulation in response to stress restores normal cholinergic activity and social behavior. However, under chronic stress, acute anti-AChE treatment or exposure, or in individuals with inherited AChE excess, AChE-R increases to a limit beyond which their cholinergic system cannot further respond and impaired social behavior is a result.
To test this hypothesis, we ascertained whether: (a) AChE-S Tg mice display excessive response to a mildly stressful stimulus, a switch in the day/night cycle; 13 (b) examined AChE-R expression in the brain neurons of AChE-S Tg mice; and (c) studied the social recognition behavior 14 of AChE-S Tg mice before and after administration of tacrine or AS3, an antisense oligonucleotide (AS-ON) shown to selectively suppress AChE-R production. 15 Our findings demonstrate constitutive mAChE-R accumulation with inter-animal variability in brain neurons of hAChE-S Tg mice, associated with an exaggerated response to changes in circadian rhythm, and impaired social recognition, which are amenable to effective AS-ON suppression.
Materials and methods

Animals
AChE-S Tg mice were obtained in a 100% FVB/N genotype from heterozygous breeding pairs. 9 Control, nonTg FVB/N mice were obtained by littermate breeding. Adult, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] wk old Tg and control male mice were housed 4-5 per cage in a 12 h dark/light cycle with free access to food and water. All experiments were conducted during the first half of the dark phase of a reversed 12 h dark/light cycle, under dim illumination. Routine locomotor activity in the home cage was measured using a remote motility detector (MFU 2100, Rhema-Labortechnik, Hofheim, Germany) to quantify changes in the electromagnetic field.
Telemetric measurements
Battery operated biotelemetric transmitters (model VM-FH, Mini Mitter, Sun River, OR, USA) were implanted in the peritoneal cavity under ether anesthesia 12 days prior to the test. After implantation, mice were housed in separate cages with free access to food and water. Output was monitored by a receiver board (model RA-1010, Mini Mitter) placed under each animal's cage and fed into a peripheral processor (BCM 100) connected to a desktop computer. Locomotor activity after the dark/light shift was measured by detecting changes in signal strength as animals moved about in their cages, so that the number of pulses that were generated by the Molecular Psychiatry transmitter was proportional to the distance the animal moved. The cumulative number of pulses generated over the noted periods was recorded. 16 Recording lasted 24 consecutive h, starting at 9:30 am, with the light phase of a 12:12 h dark/light cycle beginning at 7:00 a.m. To initiate a day/night switch, the dark/light periods were reversed and recording started 72 h after the switch and lasted 24 h. Following intraperitoneal injection of AS-ONs (see below), recording proceeded for an additional 3 h.
Social exploration tests
Each mouse was placed in a semicircular, transparent observation box and allowed 15 min for habituation, following which a juvenile male mouse (23-29 days old) was introduced. The time spent by the experimental mouse in social exploration consisted mainly of body and anogenital sniffing, chasing, attacking and crawling over the juvenile. Measurements covered a 4-min period, using a computerized event recorder. Each mouse underwent two successive social exploration sessions at the noted inter-session intervals. The first session was considered as baseline. In the second session (test), either the same or a different juvenile was introduced. Social recognition was calculated as a percentage of tested out of baseline exploration time recorded for each mouse.
In situ hybridization and AChE activity measurements Animals were killed by cervical dislocation, and brains were removed and dissected or fixed for in situ hybridization. AChE activity was measured in hippocampus, cortex and cerebellum extracts as described. 17 Protein determination was performed using a detergent-compatible kit (DC, Bio-Rad, Mü nchen, Germany). Immunoblot detection of specific AChE isoforms was as reported. 15 For in situ hybridization, 5 m paraffin sections of brain tissue were prepared after fixation by transcardial perfusion of anaesthetized mice with 4% paraformaldehyde in PBS (pH 7.4). A 50-mer fully 2Ј-O-methylated 5Ј-biotinylated AChE-R cRNA probe was applied as described. 4 Following probe detection with a streptavidin-alkaline phosphatase conjugate (Amersham Pharmacia Biotech, Little Chalfont, UK) and Fast Red as the reaction substrate (Roche Diagnostics, Mannheim, Germany), micrographs of hippocampal and cortical neurons were subjected to semi-quantitative evaluation of Fast Red staining. Mean signal intensities of light micrographs (taken with a Real-14 color digital camera, CRI, Boston, MA, USA) were analyzed using Image Pro Plus (Media Cybernetics, Silver Spring, MD, USA) image analysis software. The mean intensity of Fast Red labeling was measured in CA3 hippocampal and cortical neurons and corrected for background staining in each picture.
Immunocytochemistry
Immunocytochemistry of glial fibrillary acidic protein (GFAP) was performed as described. 8 Briefly, floating, formalin-fixed, 30 m, coronal cryostat-sections were pretreated with trypsin (type II, Sigma Chemical Co, St Louis, MO, USA) 0.001% for 1 min. Sections were incubated overnight at 4°C with a mouse anti-glial fibrillary acidic protein (GFAP) antibody (clone GA-5, Sigma-Israel, Rehovot, Israel), diluted 1:500. Then sections were incubated overnight at 4°C with horseradish peroxidase-labeled goat-anti-mouse antibody (SigmaIsrael), diluted 1:100. Color was developed by reaction with diaminobenzidine 0.0125%, nickel ammonium sulfate 0.05% and hydrogen peroxide (0.00125%). The development time of the DAB reaction product was controlled by stopwatch to ensure comparability between experiments. Sections were counterstained with cresyl violet. Quantitative analysis of the hippocampal stratum lacunosum moleculare (SLM) was performed at the level of posterior 2.5 mm from bregma. Using a 40 × objective, consecutive fields of the SLM were visualized with a Nikon microscope and processed using an AnalySIS image analysis system. A total of 35 astrocytes were sampled from each group (control vs Tg). The variables that were compared were intensity of staining of the soma (arbitrary units from a range of 256 shades of gray), soma size (m 2 ), and thickness of the largest process of each astrocyte at the process stem (m). Statistical comparisons were made using Student's t-test, with 68 degrees of freedom.
Considerations for designing antisense tests
In vivo antisense suppression of de novo AChE-R synthesis was employed throughout the current study to provide a proof of concept (ie demonstrate the causal involvement of the secretory, soluble mAChE-R variant in the excessive locomotor activity and the impaired social recognition of Tg mice). Two types of experiments were performed: (1) intracerebroventricular (i.c.v.) AS3 injection of animals subjected to longitudinal social exploration tests (up to 1 week posttreatment); and (2) i.c.v. injection followed by 1-day social exploration test, immunochemical detection and measurement of catalytic activity of brain AChE. Both of these were associated with certain inherent limitations, as detailed below, yet each test provided evidence to support part of the explored concept.
Intracranial AS-ON injection is inherently more powerful when centrally controlled behavioral parameters are sought; limitations in this case involve the duration of tests (as the animals are all at a post-surgery state) and the requirement to control for the outcome of this surgical procedure in addition to the behavioral test itself. To avoid excessive complications, we refrained from employing double operations (and, therefore, could not use telemetric measurements, which require transmitter implantation, on i.c.v.-injected animals).
The experimental controls, as well, were chosen after careful consideration. Each test should involve both Tg and control animals, as well as sham treatment (injection of either saline or an irrelevant oligonucleotide) and comparison between pre-and post-treatment phenotypes. Whenever possible, animals were self-compared, requiring careful time-of-day comparisons; in other cases, groups of animals with similar pre-treatment behavior patterns were compared to each other with regard to the efficacy of the antisense treatment. Neither of these tests is conclusive by itself, however, their cumulative outcome substantially supported the possibility of employing antisense knockdown in careful behavioral tests.
Cannula implantation
Mice under sodium pentobarbital anesthesia (50 mg kg −1 , i.p.) were placed in a stereotaxic apparatus. Skulls were exposed and a burr hole was drilled. Implantation was with a 26-gauge stainless steel guide cannula (Plastics-One, Roanoke, VA, USA). The tip of the guide cannula was positioned 1 mm above the left lateral ventricle according to the following coordinates: A: −0.4 −0.66 (bl-3.8), (bl = bregma-lamda); L: 1.5; D: −2.2. The guide cannula was secured to the skull with three stainless-steel screws and dental cement, and was closed by a dummy cannula. Mice were housed in individual cages and allowed postoperative recovery of 10-14 days before experiments.
Preparation of AS-ON
For i.c.v. injection, 2Ј-O-methyl protected (three-3Ј nucleotides) oligonucleotides (5 M) targeted against murine AChE (AS3) or BuChE (ASB) mRNA 15 were combined with 13 M of the lipophilic transfection reagent DOTAP (Roche Diagnostics) in PBS and incubated for 15 min at 37°C prior to injection. One l (25 ng) of this oligonucleotide solution was injected in each treatment.
I.c.v. administration of AS-ON
For intracranial microinjections, solutions were administered through a 33-gauge stainless steel internal cannula (Plastic One), which was 1 mm longer than the guide cannula. A PE20 tube connected the internal cannula to a microsyringe pump (KD Scientific Instruments, Boulder, CO, USA). Solutions were administered at a constant rate for 1 min, followed by 1 min during which the internal cannula was left within the guide cannula, to avoid spillage from the guide cannula. Correct positioning of the cannula was verified following each experiment by injection of trypan blue through the cannula and testing dye distribution after removal of the brains.
Statistical analysis
The results of the in situ hybridization experiment were analyzed by a t-test. The results of the circadian shift were analyzed by a three-way, repeated measures ANOVA (genotype × day (routine/reversed) × circadian phase (dark/light)). The results of the social recognition test were analyzed by a three-way, repeated measures ANOVA (genotype × stimulus animal (same or different juvenile) × intersession interval). The results of the experiment on tacrine's effect on social recognition were analyzed by a three-way ANOVA (genotype × stimulus animal (same or different juvenile) × drug (tacrine/saline)). The results of the effect of AS3 on social recognition were analyzed by a two-way, repeated measures ANOVA (pretreatment (short/long explorers) × time (days after injection)). The results of the specificity of AS3 effect were analyzed by a threeway ANOVA (genotype × drug (AS3/ASB) × time (before/after the treatment)). All ANOVAs were followed by post-hoc tests with the Fisher PLSD procedure.
Results
Transgenic mice overexpress host AChE-R
To explore the specific contribution of variant AChE mRNA transcripts towards neuronal ACHE gene expression, Tg mice overexpressing hAChE-S in the nervous system were tested by high resolution in situ hybridization using cRNA probes selective for each of the two major AChE variants. Excessive labeling was observed in hAChE-S Tg mice as compared with controls in which hybridization was performed with the AChE-S selective probe. This was consistent with the expected cumulative contribution of the overexpressed human transgene and the host mouse (m)AChE-S mRNA transcript.
9,10 However, hAChE-S Tg mice also displayed variably excessive labeling with the AChE-R cRNA probe, decorating mouse (m)AChE-R mRNA. 
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Neuronal mAChE-R mRNA overproduction in these Tg mice was heterogeneous in its extent, yet significantly higher than that in control mice. Analysis of Fast Red staining showed an increase from an average of 20 ± 3 arbitrary intensity units (± standard error of the mean, SEM) in five control animals to 41 ± 5.5 in six transgenics (t(9) = 10.27, P Ͻ 0.05). This suggested an inherited predisposition to constitutive AChE-R overproduction in Tg mice. Because AChE-R overproduction is associated with psychological stress, this further called for evaluating its neuroanatomical and behavioral manifestations.
Hypertrophy in hippocampal astrocytes reflects elevated stress in hAChE-S Tg mice
Immunocytochemical labeling of glial fibrillary acidic protein (GFAP) was used in search of an independent parameter for evaluating the stress-prone state of hAChE-S Tg mice. Hippocampal astrocytes are known from previous studies to be sensitive to various forms of stress. 18, 19 This property is manifest in morphological changes, increased size of cell soma and of astrocytic processes collectively called 'hypertrophy' and which is accompanied by increased expression of GFAP. The hippocampal SLM is particularly enriched in astrocytes, which appeared to be hypertrophic in hAChE-S Tg mice (Figure 2b Molecular Psychiatry is frequently associated with impaired cognitive and behavioral properties. 20 Intensity of staining of GFAP-like immunoreactivity in the astrocytic soma was significantly higher in Tg mice (176.3 ± 4.0, arbitrary units) compared to control mice (147.8 ± 3.5, t = 5.3, P Ͻ 0.0001). A cross-sectional area of the astrocytic soma was significantly increased in Tg (45.9 ± 1.4 m 2 ) compared to control mice (35.4 ± 1.5, t = 5.16, P Ͻ 0.0001). The stem thickness of the large astrocytic process was greater in Tg mice (1.75 ± 0.05 m) compared to control mice (1.32 ± 0.05, t = 6.21, P Ͻ 0.0001). Taken together, these data form a picture of 20-30% hypertrophy in hippocampal astrocytes of hAChE-S Tg mice, consistent with the earlier reports of stress-associated and pathology-associated astrocytic hypertrophy. 18, 19 AChE overexpression predisposes to hypersensitivity to changed circadian cycle Behavioral differences between Tg and control mice were first sought by recording locomotion patterns. Under routine conditions, both genotypes displayed similar home cage activity (Figure 3a) . Their circadian rhythms included, as expected, significantly more frequent and pronounced locomotor activity during the dark phase of the circadian cycle (F(1,24) = 18.16, P Ͻ 0.001) (summarized in Figure 3c ). Seventy-two hours following reversal of the light/dark phases, both genotypes lost most of the circadian rhythm in their locomotor activity, as reported by others, 21 but presented distinctive behavioral patterns (Figure 3b and c) . After the shift, hAChE-S Tg mice showed a general increase in activity, which was reflected in a significant genotype by day (routine vs reversed) interaction (F(1,24 = 4.68, P Ͻ 0.05). Post-hoc tests demonstrated in Tg mice significantly increased activity in the reversed cycle (compared with activity in the routine cycle), both during the dark and the light phases (P Ͻ 0.05). In addition, activity in the dark phase of the reversed cycle, was significantly greater in Tg compared with control mice. These findings indicate that adjustment to the circadian insult was markedly impaired in Tg mice, suggesting that these mice display a genetic predisposition to abnormal responses to changes in the circadian rhythm. The transgenics' intensified activity was found to be suppressed for a short time (Ͻ3 h) by i.p. administration of AS-ONs targeted to the common domain shared by all AChE mRNA variants (preliminary data, data not shown).
Impaired social recognition due to AChE excess
In the social recognition paradigm, control mice could recognize a previously encountered ('same') juvenile. This is manifest as a reduction in exploration time in the second exposure of the mice to the same, but not to a different juvenile, provided that the time interval from the end of the first encounter with that juvenile to the beginning of the memory test did not exceed 15 min. As expected, this memory decayed with increased intersession interval. In contrast, Tg mice tended to explore the previously introduced juvenile longer than control mice and did not display social recognition even after a short interval of 5 min (Figure 4 ). These findings were reflected by a significant statistical interaction between the genotype (control vs Tg) and the stimulus juvenile (same/different) (F(1,76) = 9.93, P Ͻ 0.01). In Tg mice, post-hoc analysis revealed significant reduction in exploration time only when Tg mice were tested immediately after the baseline (0 interval) with the same juvenile. These results are consistent with the cholinergic modulation of social recognition behavior. 22 The reversible AChE inhibitor, tacrine, has been clinically used for blocking acetylcholine hydrolysis and extending the impaired memory of Alzheimer's disease patients. 3 Therefore, we tested the capacity of tacrine (1.5 mg kg −1 ), injected immediately following a baseline encounter with a juvenile mouse, to improve the social recognition of Tg mice. Injected mice were tested with either the same or a different juvenile following a 10-min interval. As expected from previous reports on the beneficial effects of tacrine on social recognition in rats, 23 injection of Tg mice with tacrine induced a significant improvement in recognition memory, with post-treatment performance similar to that displayed by untreated control mice. In contrast, Tg mice displayed no recognition of the same juvenile when injected with saline, and non-Tg control mice maintained unchanged recognition performance when injected with either tacrine or saline ( Figure 5 ). These findings were reflected by a significant three-way interaction between the genotype (control/Tg), the stimulus juvenile (same/different) and the drug (tacrine/saline) (F(1,52) = 4.18, P Ͻ 0.05). In a similar experiment, in which the injections preceded the social recognition test by 40, rather than 10 min, tacrine had no effect on either Tg or control mice (data not shown). Therefore, tacrine facilitated memory consolidation when administered during the consolidation process, but did not affect acquisition of memory when given in advance.
Explorative behavior is inversely correlated with brain AChE activity
Apart from its improvement of memory, tacrine suppressed the exploration behavior toward a different juvenile in control (P Ͻ 0.05) but not in Tg mice. Decreased locomotor activity under tacrine treatment was suggested to reflect cholinergic mediation of social exploration behavior. 24 To further investigate this concept, control mice were divided into three equal groups (n = 10), presenting short, intermediate or long exploration time of the same juveniles. AChE activity was determined in the cortex and hippocampus of each subgroup, 24 h following social recognition tests of the 'same' juvenile (presented 10 min following first exposure). Mice with lower levels of cortical and hippocampal AChE activity spent more interaction time with the 'same' juvenile than mice with high AChE activity levels ( Table 1 ), so that their explorative behavior was inversely correlated with cortical and hippocampal AChE activity levels (correlation magnitude, r = −0.49 and 0.41, respectively). Compared to shorter explorers, longer explorer mice exhibited a 29% reduction in cortical AChE activity, corresponding to a Ͼ180% increase in social exploration time. The significance of the difference between the shorter and longer explorers was verified by ANOVA (F(2,27) = 4.89, P Ͻ 0.05) and post-hoc tests.
The lack of tacrine effect on the social recognition performance in control mice, and its improvement effect on the social recognition in transgenics, with approximately 50% excess AChE, 8 presented an apparent contradiction to the inverse correlation between AChE catalytic activity and social exploration. One potential explanation to this complex situation was Molecular Psychiatry that the inverse correlation in control mice reflected primarily the levels of the synaptic enzyme AChE-S; in contrast, the massive mAChE-R excess in the Tg brain could cause their impaired social recognition behavior. According to this working hypothesis, selective suppression of AChE-R should improve the social recognition performance. To test this hypothesis, we adopted i.c.v. injection of AS3 to prevent de novo mAChE-R production. 15 Mice were tested in the social exploration paradigm once before (baseline) and then 1, 3 and 6 days after two daily injections of AS3. Figure  6a presents the experimental design of these tests.
Figure 4
Working memory deficiency in Tg mice. Shown is the percent of baseline social exploration time for 8-11 wks old Tg and control male mice as a function of the intersession interval. Average baseline exploration time was 143 ± 5 s and 153 ± 5 s (± SEM) for transgenics (n = 42) and control mice (n = 48), respectively. Asterisks mark significant reductions of exploration time toward the same juvenile (P Ͻ 0.05), as compared to a different juvenile, ie short-term working memory. Increased exploration time of the same juvenile with increasing intersession intervals reflects time-dependent decay in the working memory of control mice. After a 5-min interval, Tg mice displayed no reduction in exploration time toward the same juvenile, indicating that they did not remember the same mouse for even 5 min.
AS3 improvement of social exploration increases in efficacy and duration in animals with severe pretreatment impairments
Post-treatment follow-up of social exploration was performed 1, 3 and 6 days following AS3 treatment in animals with short, medium and long pre-treatment social exploration behavior (n = 5-6 per group). As expected, there was a significant overall difference between the short and the long groups in exploration time (F(1,24) = 10.81, P Ͻ 0.05). However, post-hoc tests revealed that these groups differed significantly only during the pre-treatment day (P Ͻ 0.05), and not after the AS3 treatment (Figure 6b) . Furthermore, within the long, but not the short explorers group, social exploration of the 'same' juvenile was significantly reduced (P Ͻ 0.05) 1 day after the AS3 injection, with progressive increases in social exploration time during the 5 subsequent days. Because of the pre-treatment differences, the severely impaired animals sustained a certain level of improvement even at the sixth post-treatment day (Figure 6b ) (ie, even on this day there was no resumption of the pre-treatment difference between the short and long explorers). This experiment thus demonstrated both the efficacy and the reversibility of the antisense treatment, however with exceedingly long duration, especially in animals with severe pre-treatment impairments and in comparison to the short-term efficacy of tacrine.
Antisense AChE-R mRNA suppression selectively reduces brain AChE-R protein Tg mice with long pre-treatment explorative behavior displayed a significant improvement in social exploration of the 'same' juvenile 24 h following the second treatment with AS3, but not with the irrelevant AS-ON ASB (F(1,10) = 33.95, P Ͻ 0.001). ASB, targeted to the related enzyme, butyrylcholinesterase, served as a sequence specificity control. Control mice with either long or short pre-treatment social exploration showed no response to either AS3 or ASB (Figure 7a and data not shown). Control FVB/N male mouse population (n = 30) (3-5 months) was divided into three equal groups (n = 10) with short, intermediate and long exploration time of the same juvenile (shown as average ± SEM percent of baseline). Intersession interval was 10 min for all groups. Mice were killed 24 h after the behavior test and AChE specific activities were measured in hippocampus and cortex extracts. Asterisks mark significantly lower AChE specific activity in control long explorers as compared with short explorers (P Ͻ 0.01 for hippocampus and P Ͻ 0.05 for cortex; ANOVA followed by post-hoc tests with the Fisher PLSD procedure).
Catalytic activity measurements performed 24 h after the last AS-ON injection failed to show differences, perhaps due to the limited number of animals and the variable enzyme levels. However, immunodetected AChE-R protein levels were significantly lower in AS3 treated mice as compared with ASB treated mice, regardless of their genotype or pre-treatment behavior pattern (Figure 7b and data not shown, F(1,22) = 19.63, P Ͻ 0.001). In contrast, densitometric analysis of immunodetected total AChE protein (detected by an antibody targeted to the N-terminus, common to both isoforms) revealed essentially unchanged signals (data not shown). In further tests for potential association, post-treatment AChE-R levels were plotted as a function of the social exploration values. Data points clustered separately before the AS-ON treatment ( Figure  8a) , with both AChE-R levels and exploration times of controls clearly different from transgenics. After treatment, long explorer transgenics shifted to short exploration values (Figure 8b) . Intriguingly, the explorative behavior of long explorer controls was not affected by the treatment, indicating that the reduction in mAChE-R following AS3 treatment affected only animals that were behaviorally impaired before the treatment. Together, these findings attest to the selectivity of the antisense treatment for treating AChE-R overexpressing animals and its sequence-specificity in reversing the AChE-R induced impairment of behavior. Long-term reversibility and correlation of treatment efficacy with the severity of pre-treatment symptoms. Shown are social exploration values, in percent of baseline performance, for cannulated hAChE-S Tg mice with short and long pretreatment exploration of the 'same' juvenile, following i.c.v. AS3 treatment (n = 5 mice per group). Note that both the efficacy and the duration of the suppression effect are directly correlated with the severity of pre-treatment symptoms. *Significantly different from mice with short exploration time, at day −2 (P Ͻ 0.05).
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† Significantly different from mice with long exploration time, at day −2 (P Ͻ 0.05).
Discussion
Combination of behavioral, molecular and biochemical analyses revealed multileveled contributions of cholinergic neurotransmission and ACHE gene expression, towards the general activity and social behavior of adult Tg mice over-expressing neuronal AChE. In addition to inherited excess of hAChE-S, these Tg mice display conspicuous yet heterogeneous overexpression of the stress-associated 'readthrough' mAChE-R in their cortical and hippocampal neurons. Nevertheless, they present close to normal activity patterns under normal maintenance conditions with minimal external chal- Figure 7 AS3 decreases brain AChE-R levels and ameliorates social recognition deficits in Tg-mice. Tg (n = 36) and control (n = 22) cannula-implanted mice, 10-20 wks old, were injected i.c.v. with AS-ONs targeted against AChE (AS3) or butyrylcholinesterase (ASB) on 2 consecutive days. Social exploration of the 'same' juvenile was tested 24 h before (pre) and 24 h after (post) injections. Mice were killed immediately after the last social recognition test and brain homogenates subjected to immunodetection of AChE-R. (a) Social exploration behavior. Shown are mean social exploration of the same juvenile (percent of baseline ± SEM) before (pre) and 24 h after (post) AS-ON treatment for long explorer mice (see Table 1 ). Asterisks mark significant reduction of social exploration time after AS3 treatment (P Ͻ 0.05). Inset: Location of i.c.v. cannula in the brain (arrow). (b) Immunodetected AChE-R. Mean ± SEM densitometry values for immunodetected AChE-R in cortex extracts of the noted groups post-treatment. AChE-R levels in uncannulated control mice were considered 100%. Asterisks mark significant reduction of AChE-R levels in AS3 as compared to ASB treated mice (**P Ͻ 0.05, *P Ͻ 0.1). Note the significant reduction of immunodetected AChE-R and fragments thereof in cortices from both groups treated with AS3 as compared with those treated with the control reagent, ASB.
lenges. In contrast, their capacity to adjust to behavioral changes in response to external signals appears to be compromised, suggesting that they suffer genetic predisposition for adverse responses to stressful stimuli. 20 Behavioral and learning impairments of cholinergic origin When subjected to a day/night switch, hAChE-S Tg mice respond with excessive bursts of locomotor activity, particularly during the dark phase, but also during the light phase of the post-shift diurnal cycle. In preliminary experiments, this excessive activity could be transiently suppressed by antisense oligonucleotides, which was especially encouraging in view of the progressively impaired neuromotor functioning in these mice. 25 Matched controls, unlike transgenics, display, as expected, relatively suppressed locomotor activity during the post-shift dark phase. 26 When confronted twice with a conspecific young mouse, hAChE-S Tg mice spend significantly longer periods than controls in the social interactions characterizing such confrontations. Similarly, in a new environment, hAChE-S Tg mice displayed increased locomotor activity as compared with controls. 11 In the social recognition paradigm, they failed to remember a conspecific juvenile, even following a delay interval of only 5 min. This extends previous reports on their spatial learning and memory impairments 9, 10 and agrees with previous reports 22, 27 on the social behavior changes associated with cholinergic impairments.
Several other neurotransmission systems, eg vasopressin, 28 are most likely related, as well, with impaired social interactions. In hAChE-S Tg mice, however, this phenotype may be attributed to hypocholinergic functioning due to AChE excess, as is evident from the capacity of the AChE inhibitor tacrine to retrieve their social recognition. Nevertheless, tacrine's effects appeared surprisingly short-lived, consistent with findings of others. 29 In contrast, exceedingly low doses of oligonucleotides suppressing AChE-R synthesis exerted considerably longer-term improvement of the social recognition skills of Tg mice. This suggested non-catalytic activities as an alternative explanation(s) for the behavioral and cognitive impairments caused by AChE-R excess. 30 Circadian switch as a behavioral stressor Cholinergic neurotransmission circuits are known to be subject to circadian changes 1 and control the sensorimotor cortical regions regulating such activity. 31 Therefore, the intensified response of hAChE-S Tg mice to the circadian switch suggested that their hypocholinergic state is the cause. The variable nature of the excessive locomotor activity in the Tg mice indicates an acquired basis for its extent and duration. A potential origin of such heterogeneity could be the variable extent of neuronal mAChE-R mRNA in the sensorimotor cortex and hippocampal neurons. Both psychological 4 and physical stressors 15 induce neuronal AChE-R overproduction. Exaggerated stress responses, such as the intense locomotor response to the mild stress of a circadian switch, can hence be expected to exacerbate the hypocholinergic state of these already compromised animals.
In social behavior tests, hAChE-S Tg mice display impaired recall processes causing poor recognition when confronted with a conspecific young mouse. Therefore AChE-R overexpression, which is also induced under stress, 4 may be causally involved with the reported suppression of recall processes under stress 32 as well as with the apparent correlation between stress and hippocampal dysfunction. 33 This suggests that excess AChE-R can simultaneously impair recall processes and induce excessive locomotion. Stress-induced effects on learning and memory processes have been reported by others, 34 but were not correlated with AChE levels. Our current findings of improvement in trangenics' exploration behavior following tacrine injection, which would be expected to augment cholinergic neurotransmission, strongly indicate that their hypocholinergic state was the cause.
Advantages and limitations of anticholinesterases
In control mice, with low AChE-R levels, tacrine did not affect the normal social recognition capacity. This suggests that suppression of AChE activity may have distinct effects under normal and stress-induced conditions. Tg mice with higher AChE levels have accommodated themselves to this state, and it may be this accommodation that renders them incapable of facing a challenge by an anticholinesterase. One option is that of a threshold AChE-R activity that would be compatible both with satisfactory memory and normal locoMolecular Psychiatry motion. This balance is impaired in the Tg mice and may also be disrupted under inducers of long-term AChE-R overproduction, eg stress or exposure to anticholinesterases. 6 This, in turn, implies that the effect of anticholinesterases would depend on the initial levels of specific AChE variants in the treated mammal. Above the behaviorally-compatible threshold of AChE-R, anticholinesterases would exert behavioral improvement, whereas below it, their effects would be limited, which can explain their differential efficacy in patients with different severity of symptoms.
Glucocorticoid regulation of cholinergic behavioral patterns
The separation between general behavior patterns and learning paradigms as those relate to cholinergic transmission may explain why AChE transgenics, so dramatically impaired in their learning capacities, display such subtle deficiencies in their daily behavior. According to this concept, a constitutive hypocholinergic condition would be evident as a failure to learn and remember, however, its behavioral effect will be far less pronounced, unless challenged. This predisposition to drastic responses to external insults is indeed reminiscent of the reported behavior of demented patients. It had been initially attributed to their elevated cortisol levels, 35 which matches recent findings in primates. 36 Indeed, cortisol upregulates ACHE gene expression and elevates AChE-R levels, 37 possibly above the required threshold. In addition, both psychological stress and glucocorticoid hormones were reported to impair spatial working memory, 38, 39 consistent with such impairments in the hAChE-S Tg mice. The intensive overexpression of mAChE-R in these mice mimics a situation in which the individual capacity for AChE-R overproduction would be tightly correlated both with the severity of the behavioral impairments induced under cholinergic hypofunction and with the capacity of anticholinesterases to affect learning and behavior properties.
Brain region specificity
Working and storage memory and the ability to integrate information are tightly linked not only to cholinergic neurotransmission, but to other neurotransmitters as well. Several studies demonstrate that even mild environmental changes (like a day-to-night switch), are accompanied by increased dopamine and noradrenaline extracellular concentration in the prefrontal cortex, and only to a minor extent in the limbic and striatal areas. 40 This activation is very selective, since molecular studies have shown that thirty minutes of restraint increase Fos protein in dopamine neurons projecting to the cortex but not in those projecting to the nucleus accumbens. In this respect altered accumbens and cortical extracellular dopamine concentrations during stress are not secondary to motor activation, but instead reflect increased attention to the provocative stimulus or attempts by the intruder to 'cope' with the stimulus, and therefore are independent of a specific motor activation.
The ventral hippocampus is an important neuronal 'gate' which should be regarded as a system modulator of the cortical response to stress. In this respect cholinergic transmission may contribute to the significance of environmental cues. When neonatal ibotenic acid lesions are produced in the ventral hippocampus, repeated intraperitoneal saline injections attenuate dopamine release in the medial prefrontal cortex, while chronic haloperidol augments dopamine release in the same area of lesioned animals compared to controls. 42 This suggests that the ventral hippocampus influences the functioning of midbrain dopamine systems during environmental and pharmacological challenges in different ways. 43 Low dose and long duration of efficacy for antisense agents The short duration of the behavioral and memory improvements afforded by administration of tacrine parallels the time scale reported for the induction by such inhibitors of a transcriptional activation. 4 Together with a shift in alternative splicing this feedback response causes secondary AChE-R accumulation facilitating the hypocholinergic condition. 44 Recent reports demonstrate AChE accumulation in the cerebrospinal fluid of anticholinesterase-treated Alzheimer's disease patients, 45 suggesting that such feedback response occurs also in humans with cholinergic deficiencies 46 and perhaps explaining the gradual increase in anticholinesterase dosage that is necessary to maintain their palliative value in patients.
Unlike tacrine, the temporary antisense suppression of AChE synthesis improves social recognition in Tg mice for up to 6 days. This requires exceedingly low doses (25 ng per daily treatment) of the antisense agent, about 104-fold lower in molar terms than tacrine concentrations. Active site enzyme inhibitors should be administered in stoichiometric ratios with the large numbers of their protein target molecules. Moreover, the action of such inhibitors terminates when they reach their target. In contrast, a single chemically protected antisense molecule can cause the destruction of numerous mRNA transcripts, each capable of producing dozens of protein molecules. Assuming translation rates of approximately half-hour per chain and an average half-life of several hours for each transcript, destruction of each mRNA chain would prevent the production of many protein molecules. Therefore, the cumulative efficacy of antisense agents can exceed that of protein blockers by several orders of magnitude. 47, 48 Moreover, the palliative effects of AS-ON destroying AChE-R mRNA should extend long after the AS-ON is destroyed, because AChE-R-induced adverse consequences would occur only above a certain threshold which takes time to accumulate. Therefore, the dosedependent nature of the adverse consequences of AChE-R excess makes it particularly attractive as a target for antisense therapeutics.
We have recently found that AChE-R mRNA, having a long 3Ј untranslated domain, is significantly more sensitive to antisense destruction than the synaptic transcript. 15, 37 AChE-R mRNA transcripts would hence be preferentially destroyed, so that the excess of AChE-R, but not much of the synaptic enzyme, would decrease. This effect may explain the extended duration and increased efficacy of the antisense treatment in modifying behavior and learning exclusively in those mice with disturbed social recognition.
In conclusion, our study provides a tentative explanation for the behavioral impairments under imbalanced cholinergic neurotransmission, attributes much of these impairments to the stress-related effects of the AChE-R variant and suggests the development of antisense approach to selectively ameliorate these effects.
